InvestorsHub Logo
Followers 195
Posts 24601
Boards Moderated 0
Alias Born 04/03/2010

Re: exwannabe post# 84140

Saturday, 11/19/2016 6:50:11 AM

Saturday, November 19, 2016 6:50:11 AM

Post# of 696939
Yes, the companies can really appreciate the initiative of the universities and schools that organize these, but sometimes the organizers are not all that together. That's hard to believe in terms of the Germans, but I've seen it more frequently here in the US, at major universities. They will start to organize a trial, and maybe through inertia, it can take a really long time. My experience with the organizational skills and institutional rigor of the Germans is that this is less likely there.

I think the key is to keep one's eye on the ongoing, company driven trials, including, for now, the Phase III GBM trial especially. And let's watch out for more announcements on combination therapies, because I suspect that more are in the works.

Next issue to resolve though, is their barrier from issuing shares. Whether it's a delisting or something else, it's hard to know. But I suspect something may be in the works that we won't fully anticipate. Their situation with NASDAQ is not an easy predicament, but I believe they will trudge through it and work it out. There is usually a workable solution to anything and there is far too much here to give in the to the pessimist's meaningless rhetoric.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News